JavaScript is disabled in your browser. Please enable JavaScript to view this website.

CTSK

GeneName

CTSK

Summary

CTSK, also known as cathepsin K or cathepsin X, is a 37 kDa cysteine protease predominantly expressed in osteoclasts, where it plays a pivotal role in bone resorption and the degradation of collagen and other extracellular matrix components. This enzyme is localised to various cellular compartments, including the lysosome, endolysosome lumen, and extracellular space, facilitating its function in proteolytic processes. CTSK is involved in collagen catabolism and extracellular matrix disassembly, contributing to both normal bone remodelling and pathological conditions such as osteoporosis.

Importance

CTSK is relevant to: - Osteoporosis and other bone-related diseases due to its central role in bone resorption and collagen degradation - Cartilage development and disorders, as it negatively regulates cartilage formation - Tissue remodelling processes in various physiological and pathological contexts - Potential therapeutic target for modulating bone metabolism and treating conditions associated with excessive bone resorption

Top Products

For researchers investigating CTSK, we recommend two excellent primary antibodies. The first is the well-cited Anti-Cathepsin K antibody [3F9] (ab37259), which has garnered 43 citations and is highly regarded for its performance in Western blotting (WB), immunohistochemistry (IHC), and flow cytometry (FC). This antibody is a reliable choice for those looking to study CTSK in various applications. Additionally, we offer the recombinant antibody, Anti-Cathepsin K antibody [EP9403] (ab187647). This product has been validated for use in WB and IHC, making it a versatile option for researchers who require the consistency that recombinant antibodies provide. With 32 citations, it is also gaining recognition in the research community. Together, these antibodies provide robust tools for studying CTSK effectively.

Abcam Product Citation Summary

The data indicates that CTSK is being studied in the context of osteoclastogenesis and its expression in human bone marrow-derived macrophages. The use of Western blotting suggests a focus on protein expression levels in these studies.

Abcam Product Citation Table

Product Code
Species
Application
Study Context
PMID
ab187647
Human
WB
Osteoclastogenesis
32027437
ab207086
Human
WB
Effects of HMW-HA on cathepsin K expression
31937805

Function

Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (PubMed:11082042).

Involvement in disease

Pycnodysostosis

PKND

A rare autosomal recessive bone disorder characterized by deformity of the skull, maxilla and phalanges, osteosclerosis, and fragility of bone.

None

The disease is caused by variants affecting the gene represented in this entry.

Sequence Similarities

Belongs to the peptidase C1 family.

Tissue Specificity

Predominantly expressed in osteoclasts (bones) (PubMed:7805878). Expressed in thyroid epithelial cells (PubMed:11082042).

Cellular localization

Alternative names

CTSO, CTSO2, CTSK, Cathepsin K, Cathepsin O, Cathepsin O2, Cathepsin X

swissprot:P43235 omim:601105 entrezGene:1513